Glioma-associated antigen expression in oligodendroglial neoplasms: Tenascin and epidermal growth factor receptor

Journal of Histochemistry and Cytochemistry

Volumn 48, Issue 8, 2000, Pages 1103-1110

  McLendon, R E ^a   Wikstrand, C J ^a   Matthews, M R ^a   Al Baradei, R ^a   Bigner, S H ^a   Bigner, D D ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Epidermal growth factor receptor; Glioblastoma; Immunotherapy; Oligodendroglioma; Tumor grade

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; TENASCIN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

EID: 0033870197     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1177/002215540004800807     Document Type: Article

References (38)

1. Expression of tenascin in the developing and adult cerebellar cortex
2. The extra-cellular matrix molecule tenascin: Expression in the developing chick retinotectal system and substrate properties for retinal ganglion cell neurites in vitro
3. Epidermal growth factor ligand-independent, unregulated, cell-transforming potential of a naturally occurring human mutant EGFRvIII gene
4. Phase I studies of treatment of malignant gliomas and neoplastic meningitis with 131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F(ab')2 - A preliminary report
5. Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: Phase I trial results
6. Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization
7. Regional localization of a glioma-associated antigen defined by monoclonal antibody 81C6 in vivo: Kinetics and implications for diagnosis and therapy
8. Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody
9. Immunohistochemical investigation of p53 and EGFR expression of oligodendrogliomas
10. Intrathecal 131I-labeled antitenascin monoclonal antibody 81C6 treatment of patients with leptomeningeal neoplasms or primary brain tumor resection cavities with subarachnoid communication: Phase I trial results
11. Chemotherapy for anaplastic oligodendroglioma
12. Oligodendrogliomas. I. A clinical study of cerebral oligodendrogliomas
13. Site-restricted expression of cytotactin during development of the chicken embryo
14. The expression of tenascin-C with the AD1 variable repeat in embryonic tissues, cell lines and tumors in various vertebrate species
15. Amplification of the c-erbB oncogene is associated with malignancy in primary tumours of neuroepithelial tissue
16. Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails
17. A six-armed oligomer isolated from cell surface fibronectin preparations
18. Hexabrachion proteins in embryonic chicken tissues and human tumors
19. Regulation of oligodendrocyte precursor migration by extracellular matrix: Evidence for substrate-specific inhibition of migration by tenascin-C
20. Structure of the human hexabrachion (tenascin) gene
21. Epidermal growth factor receptors in intracranial and breast tumours: Their clinical significance
22. Tenascin-C expression in the cyst wall and fluid of human brain tumors correlates with angiogenesis
23. Tenascin-C inhibits oligodendrocyte precursor cell migration by both adhesion-dependent and adhesion-independent mechanisms
24. Histologic typing of tumours of the central nervous system
25. Human gliomas radioimmunoimaging with 131-I BC-2 murine IgG: Preliminary report
26. Therapeutic efficacy of antiglioma mesenchymal extracellular matrix 131I-radio-labeled murine monoclonal antibody in a human glioma xenograft model
27. Modified procarbazine, CCNU, and vincristine (PCV 3) combination chemotherapy in the treatment of malignant brain tumors
28. Treatment of oligodendroglioma: An update
29. Epidermal growth factor receptor expression in oligodendroglial tumors
30. Treatment of intracranial human glioblastoma by direct intratumoral administration of 131I-labelled anti-tenascin monoclonal antibody BC-2
31. Radioimmunotherapy of gastrointestinal cancer and glioblastomas
32. Human tenascin: Primary structure, pre-mRNA splicing patterns and localization of the epitopes recognized by two monoclonal antibodies
33. Amplification of the epidermal growth factor receptor gene in human gliomas
34. Tenascin expression in human glioma cell lines and normal tissues
35. Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas
36. Comparative localization of glioma-reactive monoclonal antibodies in vivo in an athymic mouse human glioma xenograft model
37. Angiogenic growth factors in neural embryogenesis and neoplasia
38. Tenascin-C expression by angiogenic vessels in human astrocytomas and by human brain endothelial cells in vitro